Growth Metrics

Fulgent Genetics (FLGT) Cash from Operations (2016 - 2026)

Fulgent Genetics' Cash from Operations history spans 12 years, with the latest figure at 7097000.0 for Q1 2026.

  • On a quarterly basis, Cash from Operations rose 260.17% to 7097000.0 in Q1 2026 year-over-year; TTM through Mar 2026 was 90110000.0, a 1062.41% decrease, with the full-year FY2025 number at 101638000.0, down 582.61% from a year prior.
  • Cash from Operations hit 7097000.0 in Q1 2026 for Fulgent Genetics, up from 78143000.0 in the prior quarter.
  • Over the last five years, Cash from Operations for FLGT hit a ceiling of 188411000.0 in Q1 2022 and a floor of 78143000.0 in Q4 2025.
  • Historically, Cash from Operations has averaged 12178941.18 across 5 years, with a median of 9737000.0 in 2023.
  • Biggest five-year swings in Cash from Operations: crashed 804.11% in 2025 and later soared 260.17% in 2026.
  • Tracing FLGT's Cash from Operations over 5 years: stood at 33207000.0 in 2022, then crashed by 55.03% to 14933000.0 in 2023, then soared by 67.53% to 25018000.0 in 2024, then plummeted by 412.35% to 78143000.0 in 2025, then soared by 109.08% to 7097000.0 in 2026.
  • Business Quant data shows Cash from Operations for FLGT at 7097000.0 in Q1 2026, 78143000.0 in Q4 2025, and 11107000.0 in Q3 2025.